Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis
Completed
LEO Pharma
Phase 3
2004-11-01
The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of
calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) gel is safe and more
effective than betamethasone 0.5 mg/g (as dipropionate) in the gel vehicle, calcipotriol 50
mcg/g in the gel vehicle or the gel vehicle used alone in patients with scalp psoriasis.
The primary outcome is the proportion of patients with absence of disease or very mild
disease after 8 weeks of treatment.
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis
Completed
LEO Pharma
Phase 3
2004-12-01
The purpose of the study is to evaluate whether once daily topical treatment for up to 8
weeks of calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) gel is safe and
more effective than betamethasone 0.5 mg/g (as dipropionate) in the gel vehicle and
calcipotriol 50 mcg/g in the gel vehicle in patients with scalp psoriasis.
The primary response criterion is the number of patients with absence of disease and very
mild disease after 8 weeks of treatment.
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis
Completed
LEO Pharma
Phase 3
2005-02-01
The purpose of the trial is to study the safety and efficacy of long term use of once daily
applications, as needed, of calcipotriol plus betamethasone dipropionate gel, as compared to
calcipotriol alone in the same gel.
The primary response criteria will be the incidence of adverse drug reactions of any type,
and the incidence of adverse events of concern associated with long-term corticosteroid use
on the scalp.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
